Bryan Cox, PhD

Dr. Cox is currently President of CoPharm Global Consulting, a boutique consultancy focused on providing guidance for biotechs and due diligence teams as they determine the best path forward from early discovery to first-in-man studies. Prior to CoPharm Global, he was Director of Integrative Pharmacology at Abbott - responsible for both lead optimization and IND-enabling studies. He served on both the Discovery and Preclinical Safety Leadership Teams. He has (co-) authored/approved over 250 documents for Regulatory submission and participated in the advancement of over 60 compounds to Phase I clinical trials. Prior to joining Abbott, Dr. Cox was with Rhone Poulenc Rorer. Dr. Cox has published more than 100 papers in peer-reviewed journals and has twice been elected to Council for the American Society of Pharmacology and Experimental Therapeutics. He received his PhD in pharmacology from the University of Iowa and is currently an adjunct Professor of Pharmacology at the University of Iowa, College of Medicine.

Jim Stolzenbach, PhD

Dr. Stolzenbach has extensive research and development experience in the pharmaceutical industry where currently he is President of Jim Stolzenbach Consulting, LLC. Jim is the former Vice President for Abbvie Renal and Immunology Therapeutic Development. Previously, he held several senior leadership roles with Monsanto and Pharmacia including Vice President for Cardiovascular and Metabolic Product Development. Jim has led global projects for both small molecule and biologic programs ranging from proof of concept trials to large Phase 3 trials designed for regulatory approval. During the course of his career he has co-authored over 30 publications in refereed journals with numerous abstracts for presentation. Jim has a Bachelor’s degree in Science from the University of Connecticut, a Master’s degree from the University of Georgia and obtained his Ph.D. at Oregon State University.

Copyright © 2019 / All rights reserved.Mount Tam Biomedical / Notices & Disclaimers